|

Evaluation Of Cardiovascular Health Outcomes Among Survivors 2

RECRUITINGN/ASponsored by St. Jude Children's Research Hospital
Actively Recruiting
PhaseN/A
SponsorSt. Jude Children's Research Hospital
Started2026-03
Est. completion2029-12
Eligibility
Age26 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07245420

Summary

Childhood cancer survivors who received certain treatments are at a higher risk of developing heart problems in the future. This study is looking at ways to educate childhood cancer survivors about that risk and encourage them to receive a recommended heart screening test.

Eligibility

Age: 26 Years+Healthy volunteers accepted
Inclusion Criteria:

* Childhood Cancer Survivor Study (CCSS) Participants
* Age ≥26 years
* Treated with cumulative doxorubicin equivalent anthracycline doses ≥100 mg/m2 with any/no radiation, or ≥15 Gy chest radiation with any/no anthracyclines
* No history of cardiomyopathy
* Has not had an echocardiogram in the previous 5 years
* Has a history of successful completion of CCSS surveys
* English-Speaking
* Has not been enrolled in ECHOS-1 (pilot)

Exclusion Criteria:

• Currently participating in a long-term follow-up program that provides risk-based screening

Conditions2

CancerHealth Behavior

Locations1 site

St. Jude Children's Research Hospital
Memphis, Tennessee, 38105
Matthew Ehrhardt, MD, MS, MPI866-278-5833referralinfo@stjude.org

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.